Plumbline Life Sciences, Inc. (XKON:222670)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,740.00
+530.00 (7.35%)
At close: Aug 1, 2025, 3:30 PM KST
7.35%
Market Cap28.37B
Revenue (ttm)n/a
Net Income (ttm)-773.99M
Shares Out3.67M
EPS (ttm)-771.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume7,742
Average Volume3,877
Open7,030.00
Previous Close7,210.00
Day's Range7,030.00 - 7,750.00
52-Week Range3,360.00 - 8,030.00
Beta0.44
RSI73.01
Earnings Daten/a

About Plumbline Life Sciences

Plumbline Life Sciences, Inc. engages in the development and sale of DNA medicines for animals. Its products include LifeTide SW5, a pig immune-modulator; PLS-ASF, a swine fever DNA vaccine; PLS-FMD; PLS-B3000, a dairy cattle DNA therapy; PLS-IF1000, a FMD vaccine; PLS-H1000, a horse laminitis therapy; PLS-D5000, a dog DNA cancer immunotherapy; PLS-D1000 for age related immune deficiency in senior dogs; and PLS-C2000 for age related immune deficiency in senior cats. Plumbline Life Sciences, Inc. was founded in 2014 and is headquartered in Seoul... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2014
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 222670
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.